文献速递骨质疏松与钙磷/甲状旁腺甲状腺疾病肥胖与代谢综合征

婴儿早期PTH抵抗综合征的临床特征:是时候改进诊断标准了吗?

Clinical picture of early-infancy PTH resistance syndromes: is it time to improve diagnostic criteria?
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

该研究回顾性分析了117例iPPSD/PHP患者,发现中位诊断年龄5.9岁,PTH抵抗和短指畸形出现晚于TSH抵抗和肥胖。2岁前64%无主要标准,71%已有至少一项次要标准,提示当前诊断标准不适用于幼儿,建议早发肥胖合并TSH升高应触发遗传筛查。

要点

  • 2岁前主要标准(PTH抵抗、短指)常缺如,64%无任何主要标准。
  • 2岁前71%已出现至少一项次要标准,20%有TSH抵抗和肥胖。
  • 早发肥胖合并TSH升高应怀疑iPPSD/PHP并尽早遗传筛查。

核心结论

  • 婴儿早期iPPSD/PHP临床表现与中晚期及成人不同,当前诊断标准可能不适用于儿童。
  • 建议早发肥胖合并TSH升高应引起怀疑并在2岁前启动遗传筛查。

研究设计与样本

  • 回顾性队列研究,纳入2个欧洲内分泌三级中心定期随访的117例iPPSD/PHP患者,收集主要临床和激素特征起病年龄。

主要发现

  • 队列中位诊断年龄为5.9岁。
  • PTH抵抗、短指畸形、TSH抵抗和肥胖的中位起病年龄分别为6.1、5.8、1.85和2岁,PTH抵抗和短指畸形起病年龄显著晚于TSH抵抗和肥胖。
  • 2岁前次要诊断标准比主要标准更常见(P = .002)。
  • 2岁前64%患者无任何主要标准,71%已出现至少一项次要标准,20%已出现TSH抵抗和肥胖。

关键数值与推荐

  • 2岁前64%无主要标准,71%有至少一项次要标准,20%有TSH抵抗和肥胖。
  • PTH抵抗、短指、TSH抵抗、肥胖的中位起病年龄分别为6.1、5.8、1.85、2岁。

临床怎么用

  • 对2岁前早发肥胖合并TSH升高的儿童,应怀疑iPPSD/PHP并考虑遗传筛查以缩短诊断延迟。

局限性

  • 回顾性研究,仅纳入2个欧洲三级中心患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Clinical presentation of inactivating parathyroid hormone (PTH)/PTH-related protein (PTHrP) signaling disorders (iPPSDs, historically pseudohypoparathyroidism [PHP]) exhibits pronounced age-dependence. Indeed, main features, including PTH resistance and brachydactyly (BD), develop during late childhood, while other features (ectopic ossifications, obesity, and hypothyroidism) are most prevalent in toddlers. The latter are included among minor diagnostic criteria; therefore, a substantial diagnostic delay has been reported. OBJECTIVE: The aim of this work is to describe the early natural history of a large cohort of iPPSD/PHP patients to improve diagnosis, with the final goal of proposing new diagnostic criteria for early infancy and reducing diagnostic delay. METHODS: We included 117 patients regularly followed up at 2 European endocrinology tertiary centers, and we retrospectively collected data on the age of onset of main clinical and hormonal features. RESULTS: In our cohort the median age at diagnosis was 5.9 years. Age of onset of PTH resistance and BD, major criteria for diagnosis, was significantly different from that of both thyrotropin (TSH) resistance and obesity (median age 6.1, 5.8, 1.85, and 2 years, respectively). Minor diagnostic criteria were more represented than major criteria in children before age 2 years (P = .002). Indeed, in 64% of patients before age 2 years none of the major criteria were observed; conversely, 71% had already developed at least one minor criterion. In particular, 20% had developed TSH resistance and obesity. CONCLUSION: The clinical picture of iPPSD/PHP in early infancy differs from that of mid-late infancy and adults, thus current diagnostic criteria may not be appropriate for children. We suggest that the combination of early-onset obesity and elevated TSH should raise suspicion and trigger genetic screening before age 2 years.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Del Sindaco G, Berkenou J, Pagnano A, et al. Clinical picture of early-infancy PTH resistance syndromes: is it time to improve diagnostic criteria? J Clin Endocrinol Metab. 2026. PMID: 41964640. doi:10.1210/clinem/dgag132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。